Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Neurogene Inc. (NGNE) Institutional Ownership & Insider Trading

112 institutions reported holding Neurogene Inc. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 17 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

NGNENeurogene Inc.Follow NGNE — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
471.3M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
11 Nov, in 18 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

112 institutions held 86.5% of the shares. Across filers that reported both quarters, shares held changed +2.0%.

Increased+36New+21Decreased-31Closed-3

Largest moves, shares (millions)

Franklin Resources+0.2MPoint72 Asset Management+0.1MMoore Capital Management+0.1MArrowMark Colorado Holdings-0.2MMillennium Management-0.2MGreat Point Partners-0.1M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-0.0Sep 24+1.8Dec 24+0.4Mar 25-1.1Jun 25-0.1Sep 25+0.4Dec 25+0.5Mar 26+0.3Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 2611217+2.0%3621313
Mar 269617+3.0%41151313
Dec 259317+2.7%2312277
Sep 258715-0.3%2115237
Jun 258115-6.5%2582610
Mar 258416+2.3%28131816
Dec 248716+13.2%29191625
Sep 248614-0.2%2019202

Neurogene Inc. — questions

Who owns Neurogene Inc. stock?
112 institutions reported Neurogene Inc. shares in 13F filings for the quarter ended 2026-06-30. The largest: SAMSARA BIOCAPITAL, LLC (8.6%), Casdin Capital, LLC (7.7%), Redmile Group, LLC (7.1%).
Are Neurogene Inc. insiders buying or selling?
17 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Neurogene Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.